Testing a faster infection test to improve antibiotic use
Part of Infections clinical trials.
This trial looks at whether a rapid molecular test can help doctors choose the right antibiotics faster for hospitalized patients. It aims to improve how antibiotics are used and reduce unnecessary side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently hospitalized at the participating hospital in Elche.
- You are starting a strong antibiotic that needs special review.
- You or your representative can sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a quality improvement program to help ICUs use fewer antibiotics without compromising patient safety. It looks at how well the intervention works to reduce antimicrobial use in critically ill patients.
This trial checks if a faster test to find the best antibiotic for a bloodstream infection can improve treatment and outcomes. If you have a confirmed bloodstream infection, you may be able to join.
This trial tests whether reporting antibiotic sensitivity results in under 6 hours helps doctors choose the right β-lactam antibiotic faster for ICU patients with certain bloodstream infections. If you are in the ICU with a Gram-negative infection, your doctors will use a quick test to pick the best treatment.
This trial tests a rapid diagnostic method that identifies the bacteria in your blood more quickly than standard tests. If it works, doctors can pick the right antibiotic sooner.
This trial is testing a new, faster way to choose the right antibiotic for people with a blood infection caused by Enterobacterales bacteria. The goal is to see if this quick test helps doctors start the most effective treatment sooner.
This trial checks whether using fast test results (PCR from samples, a blood marker called procalcitonin, and sputum appearance) can safely reduce how long you need antibiotics during a severe COPD flare. It may help you receive fewer days of antibiotics while still controlling the infection risk.
Hear when a new Antimicrobial Resistance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.